These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 6099980)

  • 1. Cutaneous Lupus Erythematosus: Review and Considerations for Older Populations.
    Heinly B; Allenzara A; Helm M; Foulke GT
    Drugs Aging; 2024 Jan; 41(1):31-43. PubMed ID: 37991658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics under the COVID-19 storm.
    Pilla Reddy V; El-Khateeb E; Jo H; Giovino N; Lythgoe E; Sharma S; Tang W; Jamei M; Rastomi-Hodjegan A
    Br J Clin Pharmacol; 2023 Jan; 89(1):158-186. PubMed ID: 33226664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute chloroquine and hydroxychloroquine toxicity: A review for emergency clinicians.
    Della Porta A; Bornstein K; Coye A; Montrief T; Long B; Parris MA
    Am J Emerg Med; 2020 Oct; 38(10):2209-2217. PubMed ID: 33071096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.
    Lei ZN; Wu ZX; Dong S; Yang DH; Zhang L; Ke Z; Zou C; Chen ZS
    Pharmacol Ther; 2020 Dec; 216():107672. PubMed ID: 32910933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FIRST REPORTS OF CLINICAL PHARMACOKINETICS IN NIGERIA.
    Michael OS
    Ann Ib Postgrad Med; 2015 Jun; 13(1):48-53. PubMed ID: 26807087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malaria prophylaxis in patients with renal impairment: a review.
    Amet S; Zimner-Rapuch S; Launay-Vacher V; Janus N; Deray G
    Drug Saf; 2013 Feb; 36(2):83-91. PubMed ID: 23371038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquine.
    Müller F; König J; Glaeser H; Schmidt I; Zolk O; Fromm MF; Maas R
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3091-8. PubMed ID: 21518836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarial drug toxicity: a review.
    Taylor WR; White NJ
    Drug Saf; 2004; 27(1):25-61. PubMed ID: 14720085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.
    Krishna S; White NJ
    Clin Pharmacokinet; 1996 Apr; 30(4):263-99. PubMed ID: 8983859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single dose disposition of chloroquine in kwashiorkor and normal children--evidence for decreased absorption in kwashiorkor.
    Walker O; Dawodu AH; Salako LA; Alván G; Johnson AO
    Br J Clin Pharmacol; 1987 Apr; 23(4):467-72. PubMed ID: 3580252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimalarial drugs. An update.
    Warhurst DC
    Drugs; 1987 Jan; 33(1):50-65. PubMed ID: 3545765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatment and prevention of malaria.
    White NJ
    Eur J Clin Pharmacol; 1988; 34(1):1-14. PubMed ID: 3282892
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of malaria--1990.
    Panisko DM; Keystone JS
    Drugs; 1990 Feb; 39(2):160-89. PubMed ID: 2183998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of chloroquine in renal insufficiency.
    Salako LA; Walker O; Iyun AO
    Afr J Med Med Sci; 1984; 13(3-4):177-82. PubMed ID: 6099980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of mecillinam after a single intravenous dose in patients with impaired renal function.
    Moukhtar I; Nawishy S; Sabbour M
    Int J Clin Pharmacol Res; 1987; 7(1):59-62. PubMed ID: 3583488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of nitrendipine in patients with renal failure: comparison to normal subjects.
    Aronoff GR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S974-6. PubMed ID: 6085387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels and half-life of sotalol in chronic renal failure.
    Sundquist HK; Anttila M; Forsström J; Kasanen A
    Ann Clin Res; 1975 Dec; 7(6):442-6. PubMed ID: 1211858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.